Case Report
Successful Desensitization of a Patient with Rituximab Hypersensitivity
Table 1
Rituximab desensitization protocol.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Solution 1: 250 mL, 5% dextrose, /0.8 mL rituximab (0.03 mg/mL: 1 : 100 of total dose, 250 mL/7.5 mg). Solution 2: 250 mL, 5% dextrose, /7.5 mL rituximab (0.30 mg/mL: 1 : 10 of total dose, 250 mL/75 mg). Solution 3: 250 mL, 5% dextrose, /74.4 mL rituximab. Premedication: 20 minutes before pheniramine 45.5 mg IV, prednisolone 100 mg IV, and famotidine 20 mg IV. |